603259 药明康德
已收盘 09-30 15:00:00
资讯
新帖
简况
券商10月金股出炉，涉及医药、信息技术等领域，药明康德、中际旭创获推荐较多（名单）
第一财经 · 17:22
券商10月金股出炉，涉及医药、信息技术等领域，药明康德、中际旭创获推荐较多（名单）
小摩增持药明康德(02359)约200.73万股 每股作价约205.6港元
智通财经 · 09-30 19:25
小摩增持药明康德(02359)约200.73万股 每股作价约205.6港元
药明康德：AI在创新药物研发领域处于探索和尝试阶段 未来有望大幅提升效率、降低门槛
格隆汇 · 09-30 18:09
药明康德：AI在创新药物研发领域处于探索和尝试阶段 未来有望大幅提升效率、降低门槛
药明康德：赋能平台承载全球30多个国家数千名合作伙伴研发创新项目
证券之星 · 09-30 17:45
药明康德：赋能平台承载全球30多个国家数千名合作伙伴研发创新项目
9月30日药明康德现3726.66万元大宗交易
证券之星 · 09-30 17:33
9月30日药明康德现3726.66万元大宗交易
药明康德AH股午后均涨超5%
格隆汇 · 09-30 13:12
药明康德AH股午后均涨超5%
药明康德（603259）披露2026年A股员工持股计划相关议案获临时股东会通过，9月29日股价下跌0.7%
证券之星 · 09-29 22:02
药明康德（603259）披露2026年A股员工持股计划相关议案获临时股东会通过，9月29日股价下跌0.7%
贝莱德增持药明康德(02359)约116.7万股 每股作价约179.83港元
智通财经 · 09-29 19:20
贝莱德增持药明康德(02359)约116.7万股 每股作价约179.83港元
药明康德获FMR LLC增持46.73万股 每股作价约208.14港元
新浪港股 · 09-27
药明康德获FMR LLC增持46.73万股 每股作价约208.14港元
FMR LLC增持药明康德(02359)46.73万股 每股作价约208.14港元
智通财经 · 09-25
FMR LLC增持药明康德(02359)46.73万股 每股作价约208.14港元
药明康德(02359)：67.8亿元于2027年到期的美元结算零息可转换债券悉数转换并撤销上市地位
智通财经 · 09-23
药明康德(02359)：67.8亿元于2027年到期的美元结算零息可转换债券悉数转换并撤销上市地位
药明康德：9月23日转换可转换债券120.7万股
南方财经网 · 09-23
药明康德：9月23日转换可转换债券120.7万股
药明康德：近期收到部分债券持有人进一步行使债券附带的转换权的请求
美股速递 · 09-21
药明康德：近期收到部分债券持有人进一步行使债券附带的转换权的请求
药明康德减持药明合联：套现39亿港元 仍是重要股东
雷递 · 09-16
药明康德减持药明合联：套现39亿港元 仍是重要股东
药明康德(02359)因零息可转换债券获转换而发行54.32万股
智通财经 · 09-16
药明康德(02359)因零息可转换债券获转换而发行54.32万股
药明康德：9月16日发行新股543152股
南方财经网 · 09-16
药明康德：9月16日发行新股543152股
9月14日药明康德涨5.04%，医药ETF易方达基金重仓该股
证券之星 · 09-14
9月14日药明康德涨5.04%，医药ETF易方达基金重仓该股
药明康德H股盘中涨超5%，高盛认为中国CRO/CDMO行业正明确复苏
同花顺 · 09-14
药明康德H股盘中涨超5%，高盛认为中国CRO/CDMO行业正明确复苏
每周股票复盘：药明康德（603259）本周因可转债转换多次增发H股
证券之星 · 09-13
每周股票复盘：药明康德（603259）本周因可转债转换多次增发H股
药明康德（603259）披露H股因可转债转股新增发行公告，9月11日股价下跌2.11%
证券之星 · 09-11
药明康德（603259）披露H股因可转债转股新增发行公告，9月11日股价下跌2.11%
加载更多
公司概况
公司名称：
无锡药明康德新药开发股份有限公司
所属行业：
研究和试验发展
上市日期：
2018-05-08
主营业务：
无锡药明康德新药开发股份有限公司的主营业务是为全球医药及生命科学行业提供一体化、端到端的新药研发和生产服务。公司的主要产品是化学业务、测试业务、生物学业务、其他业务。
发行价格：
21.60
{"stockData":{"symbol":"603259","market":"SH","secType":"STK","nameCN":"药明康德","latestPrice":167.34,"timestamp":1790751600000,"preClose":160.66,"halted":0,"volume":44950902,"delay":0,"changeRate":0.0416,"floatShares":2473000000,"shares":3035000000,"eps":7.1403,"marketStatus":"已收盘","change":6.68,"latestTime":"09-30 15:00:00","open":160.01,"high":169.2,"low":159.4,"amount":7442000000,"amplitude":0.061,"askPrice":167.35,"askSize":230,"bidPrice":167.34,"bidSize":165,"shortable":0,"etf":0,"ttmEps":7.1403,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1791423000000},"marketStatusCode":5,"adr":0,"adjPreClose":160.66,"symbolType":"stock","openAndCloseTimeList":[[1790731800000,1790739000000],[1790744400000,1790751600000]],"highLimit":176.73,"lowLimit":144.59,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":3034904066,"isCdr":false,"pbRate":6.09,"roa":"--","peRate":23.43599,"roe":"13.19%","epsLYR":6.7,"committee":0.349043,"marketValue":507860999999.9999,"turnoverRate":0.0182,"status":0,"nextConnectDate":"根据港交所公布的数据，今日已停止北向交易，下一个交易日为北京时间 2026-10-08。","hkstockBrief":{"symbol":"02359","market":"HK","secType":"STK","nameCN":"药明康德","latestPrice":215.2,"timestamp":1790755707003,"preClose":207.8,"halted":0,"volume":5979249,"delay":0,"premium":"+10.11"},"floatMarketCap":413879000000},"requestUrl":"/m/hq/s/603259","defaultTab":"news","newsList":[{"id":"2672875510","title":"券商10月金股出炉，涉及医药、信息技术等领域，药明康德、中际旭创获推荐较多（名单）","url":"https://stock-news.laohu8.com/highlight/detail?id=2672875510","media":"第一财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2672875510?lang=zh_cn&edition=full","pubTime":"2026-10-01 17:22","pubTimestamp":1790846520,"startTime":"0","endTime":"0","summary":"炒股就看金麒麟分析师研报，权威，专业，及时，全面，助您挖掘潜力主题机会！药明康德最受机构青睐，共入围了8家券商的推荐名单。截至发稿，逾10家券商公布了10月月度投资组合，涉及医药、信息技术、材料、消费等多个领域。哪些个股收获点名最多？据不完全统计，在各家券商的“金股”名单中，药明康德最受机构青睐，共入围了8家券商的推荐名单；其次是中际旭创，获得4家券商集体看好；海信视像、中国巨石均获得3家券商推荐。其中，药明康德在9月内涨幅最多，股价累计涨超8%，最新收盘价报167.34元；中国巨石9月震荡走低，月度累计下跌超10%，最新收盘价报39.41元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/roll/2026-10-01/doc-inittkrz1102637.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/roll/2026-10-01/doc-inittkrz1102637.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["91530","LU1719994722.HKD","BK0070","BK4544","LU0039217434.USD","LU2476274720.SGD","IE0032431581.USD","LU0164865239.USD","LU2148510915.USD","HK0000320264.USD","LU0052750758.USD","LU0348767384.USD","LU0417516738.SGD","LU0572944931.SGD","LU1146622755.USD","SG9999011746.SGD","LU0359202008.SGD","KCE","LU0700851271.USD","LU0231483743.USD","603259","02359","ARKG","BK0028","IE00BPRC5H50.USD","LU1046422090.SGD","BK1533","03308","HK0000306685.HKD","LU1064130708.USD","LU0708995583.HKD","SGXZ81163826.USD","BK0077","VGT","09939","159938","300308","BK4585","LU2213484517.USD","LU1997244956.HKD","IE00BYQNZ168.SGD","LU0082770016.SGD","LU0348827113.USD","159939","IE00B12V2V27.USD","IE00BYTNYN87.SGD","BK4588","LU2488822045.USD","LU0359201612.USD","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671020964","title":"小摩增持药明康德(02359)约200.73万股 每股作价约205.6港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2671020964","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2671020964?lang=zh_cn&edition=full","pubTime":"2026-09-30 19:25","pubTimestamp":1790767544,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，香港联交所最新数据显示，9月24日，小摩增持药明康德(02359)200.7296万股，每股作价205.5962港元，总金额约为4.13亿港元。增持后最新持股数目约为5253.64万股，持股比例为9.35%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1502822.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU0611395673.USD","LU0327786744.USD","LU0820562030.AUD","LU0106261372.USD","BK4588","IE000F7OJYX1.SGD","LU2054465674.USD","BK1141","LU2237443622.USD","LU1084165304.USD","LU0048584097.USD","LU1914381329.SGD","LU2756315664.SGD","LU0345769631.USD","UYG","LU1363072403.SGD","LU2242649171.HKD","EWH","LU1988902786.USD","LU2106854487.HKD","LU1496350502.SGD","IE00BJTD4N35.SGD","FTXO","LU2244417387.USD","02359","603259","LU1366333091.USD","KBWB","IE00BKVL7J92.USD","LU0787776722.HKD","FNCL","IXG","JPO","LU0251132253.USD","IE00BBT3K403.USD","TFNS","VFH","XLF","LU0417517546.SGD","IYF","LU2357305700.SGD","LU0211326839.USD","BK4504","IYG","LU1261432733.SGD","LU2488822045.USD","LU0700851271.USD","LU2381873111.SGD","JPMO","TRUF"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671790208","title":"药明康德：AI在创新药物研发领域处于探索和尝试阶段 未来有望大幅提升效率、降低门槛","url":"https://stock-news.laohu8.com/highlight/detail?id=2671790208","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2671790208?lang=zh_cn&edition=full","pubTime":"2026-09-30 18:09","pubTimestamp":1790762979,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["LU1251922891.USD","LU1719994722.HKD","LU0456842615.SGD","LU2495084118.USD","IE00B543WZ88.USD","LU0611395673.USD","IE00BPRC5H50.USD","LU1997245177.USD","LU1770034418.SGD","LU1303224171.USD","LU1808992512.USD","LU1997245094.SGD","LU1934453819.USD","BK0216","IE00B5MMRT66.SGD","LU2488822045.USD","LU0700851271.USD","LU2328871848.SGD","LU1979443071.USD","LU1969619763.USD","LU1997244956.HKD","603259"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671270097","title":"药明康德：赋能平台承载全球30多个国家数千名合作伙伴研发创新项目","url":"https://stock-news.laohu8.com/highlight/detail?id=2671270097","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2671270097?lang=zh_cn&edition=full","pubTime":"2026-09-30 17:45","pubTimestamp":1790761521,"startTime":"0","endTime":"0","summary":"证券之星消息，药明康德(603259)09月30日在投资者关系平台上答复投资者关心的问题。投资者提问：请问贵司的客户有哪些大型药企，劳烦请举例说明，谢谢。药明康德回复：您好，感谢您对公司的关注。公司是全球医药及生命科学行业值得信赖的合作伙伴和重要贡献者，致力于通过提供一体化、端到端的新药研发和生产服务，推动全球医药健康创新。公司尊重客户商业机密，不评论任何具体客户情况。目前，公司的赋能平台正承载着来自全球30多个国家的数千名合作伙伴的研发创新项目，致力于将更多新药、好药带给全球病患。本文数据来源于上海证券交易所e互动，仅供参考不构成投资建议。相关 ETF责任编辑：刘浩然","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026093000028584.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU0611395673.USD","LU0708995583.HKD","LU1719994722.HKD","LU2242644610.SGD","LU0348767384.USD","LU2328871848.SGD","LU1997244956.HKD","BK1141","LU0572944931.SGD","LU1251922891.USD","BK1576","LU0320764599.SGD","LU1046422090.SGD","LU1997245094.SGD","02359","LU1979443071.USD","LU2045819591.USD","LU0327786744.USD","LU0456842615.SGD","LU2125910500.SGD","BK0216","LU0052750758.USD","IE00B543WZ88.USD","IE00B5MMRT66.SGD","LU1303224171.USD","LU0700851271.USD","IE00BPRC5H50.USD","LU1808992512.USD","603259","LU0348766576.USD","LU2495084118.USD","LU0469268626.HKD","LU1934453819.USD","BK1583","LU1770034418.SGD","LU1969619763.USD","LU1997245177.USD","LU2488822045.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671270628","title":"9月30日药明康德现3726.66万元大宗交易","url":"https://stock-news.laohu8.com/highlight/detail?id=2671270628","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2671270628?lang=zh_cn&edition=full","pubTime":"2026-09-30 17:33","pubTimestamp":1790760839,"startTime":"0","endTime":"0","summary":"证券之星消息，9月30日药明康德发生大宗交易，交易数据如下：近三个月该股共发生19笔大宗交易，合计成交2.03万手。该股近期无解禁股上市。截至2026年9月30日收盘，药明康德(603259)报收于167.34元，上涨4.16%，换手率1.82%，成交量44.95万手，成交额74.42亿元。该股最近90天内共有30家机构给出评级，买入评级27家，增持评级3家；过去90天内机构目标均价为197.88。本文数据来源于上海证券交易所大宗交易信息披露，仅供参考不构成投资建议。相关 ETF","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026093000027877.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU0327786744.USD","LU0700851271.USD","LU1997244956.HKD","LU0348767384.USD","603259","LU0611395673.USD","BK0216","LU1251922891.USD","LU2488822045.USD","IE00BPRC5H50.USD","LU0572944931.SGD","LU2242644610.SGD","LU1969619763.USD","LU0708995583.HKD","IE00B5MMRT66.SGD","LU2045819591.USD","BK1141","LU1046422090.SGD","IE00B543WZ88.USD","LU1997245094.SGD","LU1979443071.USD","BK1583","LU0320764599.SGD","LU0348766576.USD","02359","LU0052750758.USD","LU1770034418.SGD","LU0469268626.HKD","LU1934453819.USD","LU0456842615.SGD","LU2495084118.USD","BK1576","LU1997245177.USD","LU2125910500.SGD","LU1808992512.USD","LU1303224171.USD","LU1719994722.HKD","LU2328871848.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671607220","title":"药明康德AH股午后均涨超5%","url":"https://stock-news.laohu8.com/highlight/detail?id=2671607220","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2671607220?lang=zh_cn&edition=full","pubTime":"2026-09-30 13:12","pubTimestamp":1790745132,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["IE00B5MMRT66.SGD","LU0572944931.SGD","LU2495084118.USD","LU1997245177.USD","LU2328871848.SGD","LU1997245094.SGD","02359","LU1046422090.SGD","LU0327786744.USD","LU0052750758.USD","BK1583","LU0708995583.HKD","BK1141","LU0348766576.USD","BK0216","LU2242644610.SGD","LU1303224171.USD","LU1969619763.USD","LU0320764599.SGD","IE00B543WZ88.USD","LU0456842615.SGD","LU2488822045.USD","LU1719994722.HKD","LU1251922891.USD","LU0348767384.USD","LU1808992512.USD","LU1770034418.SGD","LU0469268626.HKD","LU2045819591.USD","LU2125910500.SGD","LU1934453819.USD","LU0611395673.USD","LU1997244956.HKD","LU1979443071.USD","IE00BPRC5H50.USD","BK1576","603259","LU0700851271.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671210149","title":"药明康德（603259）披露2026年A股员工持股计划相关议案获临时股东会通过，9月29日股价下跌0.7%","url":"https://stock-news.laohu8.com/highlight/detail?id=2671210149","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2671210149?lang=zh_cn&edition=full","pubTime":"2026-09-29 22:02","pubTimestamp":1790690531,"startTime":"0","endTime":"0","summary":"截至2026年9月29日收盘，药明康德报收于160.66元，较前一交易日下跌0.7%，最新总市值为4875.88亿元。该股当日开盘161.81元，最高166.68元，最低159.47元，成交额达49.28亿元，换手率为1.23%。所有议案均获通过，无否决议案。会议由董事长Ge Li（李革）博士主持，表决方式符合《公司法》及《公司章程》规定。国浩律师（上海）事务所对本次会议进行了见证并出具法律意见书，认为会议召集、召开程序合法，决议合法有效。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092900039544.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU0320764599.SGD","82823","BK1610","02823","LU1979443071.USD","LU2488822045.USD","82822","07233","LU0469268626.HKD","LU0572944931.SGD","83130","BK1576","LU1046422090.SGD","LU0348766576.USD","02822","603259","LU0611395673.USD","LU1969619763.USD","LU2328871848.SGD","LU1997245094.SGD","02359","03130","LU1251922891.USD","03188","82846","LU0052750758.USD","BK1141","LU0708995583.HKD","IE00B543WZ88.USD","399300","82843","LU2125910500.SGD","LU1770034418.SGD","LU0700851271.USD","LU1997245177.USD","02827","02846","LU1997244956.HKD","LU2242644610.SGD","83188","LU2495084118.USD","LU1934453819.USD","LU2045819591.USD","159982","BK1583","LU1719994722.HKD","LU1808992512.USD","LU0348767384.USD","02843","LU1303224171.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671219598","title":"贝莱德增持药明康德(02359)约116.7万股 每股作价约179.83港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2671219598","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2671219598?lang=zh_cn&edition=full","pubTime":"2026-09-29 19:20","pubTimestamp":1790680839,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，香港联交所最新数据显示，9月24日，贝莱德增持药明康德(02359)116.7015万股，每股作价179.8314港元，总金额约为2.1亿港元。增持后最新持股数目约为2899.81万股，最新持股比例为5.16%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1502222.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU2495084118.USD","IE00BPRC5H50.USD","LU1979443071.USD","LU0348766576.USD","LU2242644610.SGD","603259","LU1997244956.HKD","BK1141","LU1719994722.HKD","LU1251922891.USD","LU2125910500.SGD","LU0469268626.HKD","LU0327786744.USD","LU1969619763.USD","LU1997245177.USD","LU2328871848.SGD","IE00B5MMRT66.SGD","02359","BK1576","LU0348767384.USD","LU1808992512.USD","LU0456842615.SGD","IE00B543WZ88.USD","LU1934453819.USD","LU0708995583.HKD","LU2488822045.USD","LU0700851271.USD","LU1303224171.USD","LU0611395673.USD","LU2045819591.USD","EWH","LU0052750758.USD","BK1583","LU0320764599.SGD","BK0216","LU1997245094.SGD","LU1770034418.SGD","LU1046422090.SGD","LU0572944931.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670704124","title":"药明康德获FMR LLC增持46.73万股 每股作价约208.14港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2670704124","media":"新浪港股","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2670704124?lang=zh_cn&edition=full","pubTime":"2026-09-27 12:21","pubTimestamp":1790482860,"startTime":"0","endTime":"0","summary":"热点栏目自选股\n数据中心\n行情中心\n资金流向\n模拟交易客户端香港联交所最新数据显示，9月22日，FMR LLC增持药明康德（02359）46.73万股，每股作价208.1367港元，总金额约为9726.23万港元。增持后最新持股数目约为5641.78万股，持股比例为10.07%。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2026-09-27/doc-initftkp4852021.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LU2495084118.USD","IE00BPRC5H50.USD","LU1979443071.USD","LU0348766576.USD","LU2242644610.SGD","603259","LU1997244956.HKD","BK1141","LU1719994722.HKD","LU1251922891.USD","LU2125910500.SGD","LU0469268626.HKD","LU0327786744.USD","LU1969619763.USD","LU1997245177.USD","LU2328871848.SGD","IE00B5MMRT66.SGD","02359","BK1576","LU0348767384.USD","LU1808992512.USD","LU0456842615.SGD","IE00B543WZ88.USD","LU1934453819.USD","LU0708995583.HKD","LU2488822045.USD","LU0700851271.USD","LU1303224171.USD","LU0611395673.USD","LU2045819591.USD","EWH","LU0052750758.USD","BK1583","LU0320764599.SGD","BK0216","LU1997245094.SGD","LU1770034418.SGD","LU1046422090.SGD","LU0572944931.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670421674","title":"FMR LLC增持药明康德(02359)46.73万股 每股作价约208.14港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2670421674","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2670421674?lang=zh_cn&edition=full","pubTime":"2026-09-25 19:16","pubTimestamp":1790334962,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，香港联交所最新数据显示，9月22日，FMR LLC增持药明康德(02359)46.73万股，每股作价208.1367港元，总金额约为9726.23万港元。增持后最新持股数目约为5641.78万股，持股比例为10.07%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1501025.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU1934453819.USD","LU1808992512.USD","LU0572944931.SGD","LU0700851271.USD","LU1770034418.SGD","LU2488822045.USD","LU2045819591.USD","LU0348767384.USD","BK1583","LU0320764599.SGD","LU1997245177.USD","IE00B5MMRT66.SGD","LU0469268626.HKD","LU1997244956.HKD","LU2328871848.SGD","LU1303224171.USD","LU1251922891.USD","LU0052750758.USD","LU1719994722.HKD","LU1046422090.SGD","LU1979443071.USD","IE00B543WZ88.USD","BK1576","LU2495084118.USD","LU0611395673.USD","BK0216","LU1969619763.USD","LU0327786744.USD","LU0348766576.USD","BK1141","LU1997245094.SGD","EWH","LU0708995583.HKD","IE00BPRC5H50.USD","02359","LU0456842615.SGD","LU2242644610.SGD","603259","LU2125910500.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669100394","title":"药明康德(02359)：67.8亿元于2027年到期的美元结算零息可转换债券悉数转换并撤销上市地位","url":"https://stock-news.laohu8.com/highlight/detail?id=2669100394","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669100394?lang=zh_cn&edition=full","pubTime":"2026-09-23 18:50","pubTimestamp":1790160636,"startTime":"0","endTime":"0","summary":"智通财经APP讯，药明康德(02359)发布公告，内容有关(其中包括)发行人民币67.8亿元于2027年到期的美元结算零息可转换债券及提前赎回债券。于本公告日期，所有未偿还债券已根据债券条款及条件悉数转换为公司H股。因此，于本公告日期概无任何未偿还的已发行债券，提前赎回债券的安排亦将因此不再进行。撤销债券于维也纳证券交易所的上市预期将于2026年9月25日的维也纳证券交易所交易时间开始时生效。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1499968.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["CVRT","BK1583","IE00B5MMRT66.SGD","BK4164","UUP","603259","LU0348766576.USD","LU0708995583.HKD","LU1770034418.SGD","LU0572944931.SGD","LU0456842615.SGD","02359","LU1979443071.USD","LU1046422090.SGD","LU0320764599.SGD","LU1997245094.SGD","LU2495084118.USD","IPOS","LU1251922891.USD","LU2045819591.USD","LU0611395673.USD","BK0216","LU0348767384.USD","UDN","LU0469268626.HKD","LU0052750758.USD","LU1808992512.USD","LU2328871848.SGD","LU1719994722.HKD","LU1997244956.HKD","LU2242644610.SGD","LU1303224171.USD","LU2125910500.SGD","IE00BPRC5H50.USD","LU0700851271.USD","LU2488822045.USD","LU0327786744.USD","LU1969619763.USD","MCVT","BK1576","IE00B543WZ88.USD","BK1141","LU1934453819.USD","LU1997245177.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669092631","title":"药明康德：9月23日转换可转换债券120.7万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2669092631","media":"南方财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669092631?lang=zh_cn&edition=full","pubTime":"2026-09-23 16:33","pubTimestamp":1790152380,"startTime":"0","endTime":"0","summary":"南财智讯9月23日电，药明康德（02359.HK）发布翌日披露报表，2026年9月23日，公司根据人民币67.8亿元于2027年到期之美元结算零息可转换债券转换及发行H股120.7万股，每股发行价为153港元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202609233882469945.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202609233882469945.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU2045819591.USD","LU2125910500.SGD","IE00B543WZ88.USD","LU1934453819.USD","IE00BPRC5H50.USD","MCVT","LU2495084118.USD","BK1576","LU0456842615.SGD","LU0469268626.HKD","LU0348767384.USD","LU2488822045.USD","LU0611395673.USD","LU2328871848.SGD","LU1251922891.USD","BK0216","LU1770034418.SGD","LU0572944931.SGD","LU1997245177.USD","BK1141","BK4164","IE00B5MMRT66.SGD","LU1808992512.USD","LU0052750758.USD","LU1969619763.USD","LU0708995583.HKD","LU1046422090.SGD","LU2242644610.SGD","BK1583","CVRT","LU0320764599.SGD","LU1997244956.HKD","LU0327786744.USD","02359","LU1303224171.USD","LU0348766576.USD","LU0700851271.USD","LU1979443071.USD","LU1719994722.HKD","LU1997245094.SGD","603259"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1194402197","title":"药明康德：近期收到部分债券持有人进一步行使债券附带的转换权的请求","url":"https://stock-news.laohu8.com/highlight/detail?id=1194402197","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1194402197?lang=zh_cn&edition=full","pubTime":"2026-09-21 18:38","pubTimestamp":1789987114,"startTime":"0","endTime":"0","summary":"药明康德近期透露，公司收到来自部分债券持有人的更多请求，这些请求关乎行使债券所附带的转换权。这一动态，无疑为市场参与者提供了新的关注点。\n据悉，这一进展标志着公司债务管理及资本市场互动中的一个值得注意的节点。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1808992512.USD","LU1303224171.USD","LU0052750758.USD","LU1969619763.USD","LU1997245177.USD","BK1141","IE00B543WZ88.USD","LU1997244956.HKD","LU2328871848.SGD","LU0348766576.USD","LU2488822045.USD","02359","BK1576","LU1934453819.USD","LU1046422090.SGD","603259","LU2045819591.USD","LU1979443071.USD","LU2495084118.USD","LU0572944931.SGD","LU0708995583.HKD","LU0456842615.SGD","LU2242644610.SGD","LU2125910500.SGD","LU1770034418.SGD","LU0320764599.SGD","IE00B5MMRT66.SGD","LU0348767384.USD","BK1583","BK0216","LU0469268626.HKD","IE00BPRC5H50.USD","LU0327786744.USD","LU0611395673.USD","LU0700851271.USD","LU1251922891.USD","LU1997245094.SGD","LU1719994722.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668980644","title":"药明康德减持药明合联：套现39亿港元 仍是重要股东","url":"https://stock-news.laohu8.com/highlight/detail?id=2668980644","media":"雷递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2668980644?lang=zh_cn&edition=full","pubTime":"2026-09-16 19:43","pubTimestamp":1789558980,"startTime":"0","endTime":"0","summary":"药明康德曾多次套现，其中，2024年11月8日和2025年1月10日，通过两次大宗交易累计出售药明合联8600万股，套现约24.26亿港元;药明康德2025年4月出售5080万股，套现21.78亿港元；2025年10月再度出售3030万股，成交金额约23.46亿港元。这意味着，药明康德在不到两年时间，已从药明合联套现108亿港元。不过，药明康德仍是药明合联重要股东，持股比例仍达到14%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://mp.weixin.qq.com/s?__biz=MjM5MzQ5NjIyMQ==&mid=2661684737&idx=8&sn=4a7f7c6e4268d3536526d38c6eb54944&chksm=bc226477c4ee011ff6853766226a80d7fedce7ca2276c132cf3783192bb74d9ab9d39817a526&scene=0#rd","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"weixin_highlight","symbols":["LU1997245094.SGD","LU0456842615.SGD","LU1934453819.USD","LU1969619763.USD","LU2328871848.SGD","LU2495084118.USD","IE00BPRC5H50.USD","LU1997244956.HKD","LU1719994722.HKD","IE00B543WZ88.USD","LU1770034418.SGD","BK0216","LU1251922891.USD","LU0611395673.USD","LU0700851271.USD","LU1303224171.USD","LU2488822045.USD","LU1808992512.USD","LU1997245177.USD","IE00B5MMRT66.SGD","LU1979443071.USD","603259"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667606945","title":"药明康德(02359)因零息可转换债券获转换而发行54.32万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2667606945","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2667606945?lang=zh_cn&edition=full","pubTime":"2026-09-16 16:32","pubTimestamp":1789547520,"startTime":"0","endTime":"0","summary":"智通财经APP讯，药明康德(02359)发布公告，于2026年9月16日，该公司根据人民币6,780百万元于2027年到期之美元结算零息可转换债券而转换及发行54.32万股H股。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1496791.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU0700851271.USD","LU1719994722.HKD","LU2045819591.USD","LU1997245177.USD","LU1979443071.USD","LU1934453819.USD","LU1046422090.SGD","BK1576","LU1251922891.USD","LU1303224171.USD","MCVT","LU0327786744.USD","LU0469268626.HKD","CVRT","LU1770034418.SGD","603259","LU0572944931.SGD","LU0611395673.USD","LU0456842615.SGD","LU1997244956.HKD","IE00BPRC5H50.USD","02359","BK1583","IE00B543WZ88.USD","LU2242644610.SGD","LU0348767384.USD","LU2488822045.USD","LU0052750758.USD","LU2125910500.SGD","LU2328871848.SGD","BK4164","LU1969619763.USD","LU2495084118.USD","LU0708995583.HKD","BK0216","LU0348766576.USD","IE00B5MMRT66.SGD","BK1141","LU1808992512.USD","LU0320764599.SGD","LU1997245094.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667606776","title":"药明康德：9月16日发行新股543152股","url":"https://stock-news.laohu8.com/highlight/detail?id=2667606776","media":"南方财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2667606776?lang=zh_cn&edition=full","pubTime":"2026-09-16 16:32","pubTimestamp":1789547520,"startTime":"0","endTime":"0","summary":"南财智讯9月16日电，药明康德（02359.HK）发布翌日披露报表，因转换美元结算零息可转换债券而发行H股，事件日期为9月16日，发行新股543152股，占有关事件前的现有已发行股份（不包括库存股份）数目0.1%，每股发行价153港元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202609163876074334.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202609163876074334.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU2328871848.SGD","LU0708995583.HKD","LU2488822045.USD","LU0456842615.SGD","LU1997244956.HKD","LU1719994722.HKD","LU2045819591.USD","BK1576","LU1251922891.USD","LU2242644610.SGD","LU1808992512.USD","IE00B5MMRT66.SGD","LU0469268626.HKD","LU0348766576.USD","LU2125910500.SGD","BK1583","IE00BPRC5H50.USD","LU0320764599.SGD","LU1997245094.SGD","LU1934453819.USD","603259","BK0216","BK1141","LU1770034418.SGD","IE00B543WZ88.USD","LU0611395673.USD","LU1046422090.SGD","LU1303224171.USD","LU1969619763.USD","LU1979443071.USD","LU0348767384.USD","02359","LU0052750758.USD","LU0700851271.USD","LU0572944931.SGD","LU1997245177.USD","LU2495084118.USD","LU0327786744.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667253659","title":"9月14日药明康德涨5.04%，医药ETF易方达基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2667253659","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2667253659?lang=zh_cn&edition=full","pubTime":"2026-09-14 16:35","pubTimestamp":1789374937,"startTime":"0","endTime":"0","summary":"证券之星消息，9月14日药明康德涨5.04%，收盘报158.86元，换手率1.78%，成交量44.03万手，成交额68.69亿元。根据2026基金半年报公募基金重仓股数据，重仓该股的公募基金共739家，其中持有数量最多的公募基金为易方达基金的医药ETF易方达。医药ETF易方达的前十大重仓股如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091400021092.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU1770034418.SGD","02359","LU1997244956.HKD","LU2242644610.SGD","LU0469268626.HKD","LU2125910500.SGD","LU0052750758.USD","LU1997245094.SGD","603259","IE00B543WZ88.USD","LU2328871848.SGD","BK1583","512010","LU0700851271.USD","LU2488822045.USD","LU0572944931.SGD","IE00B5MMRT66.SGD","LU1303224171.USD","LU1046422090.SGD","BK1576","LU0348766576.USD","LU1808992512.USD","LU0320764599.SGD","LU0348767384.USD","LU0456842615.SGD","BK1141","BK0216","IE00BPRC5H50.USD","LU1719994722.HKD","LU2045819591.USD","LU0611395673.USD","LU1969619763.USD","LU1979443071.USD","LU1934453819.USD","LU2495084118.USD","LU1997245177.USD","LU1251922891.USD","LU0327786744.USD","LU0708995583.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667655623","title":"药明康德H股盘中涨超5%，高盛认为中国CRO/CDMO行业正明确复苏","url":"https://stock-news.laohu8.com/highlight/detail?id=2667655623","media":"同花顺","labels":["economic"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2667655623?lang=zh_cn&edition=full","pubTime":"2026-09-14 13:46","pubTimestamp":1789364760,"startTime":"0","endTime":"0","summary":"9月14日，药明康德(02359.HK)盘中涨超5%，截至13时43分，涨5.03%，报198.30港元/股，成交额47053.63万港元。消息面上，高盛(GS.US)发布研报称，今年第二季度及上半年业绩反映中国CRO/CDMO行 ...","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tonghuashun","url":"http://stock.10jqka.com.cn/20260914/c679873113.shtml","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://stock.10jqka.com.cn/20260914/c679873113.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"economic","news_rank":0,"length":0,"strategy_id":0,"source":"tonghuashun","symbols":["603259","LU1251922891.USD","LU1808992512.USD","BK0216","LU0611395673.USD","IE00BPRC5H50.USD","LU1969619763.USD","LU1997245094.SGD","LU1997244956.HKD","LU2488822045.USD","LU0456842615.SGD","LU1979443071.USD","LU2495084118.USD","LU1770034418.SGD","IE00B543WZ88.USD","IE00B5MMRT66.SGD","LU1719994722.HKD","LU0700851271.USD","LU1303224171.USD","LU1997245177.USD","LU2328871848.SGD","LU1934453819.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667502479","title":"每周股票复盘：药明康德（603259）本周因可转债转换多次增发H股","url":"https://stock-news.laohu8.com/highlight/detail?id=2667502479","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2667502479?lang=zh_cn&edition=full","pubTime":"2026-09-13 01:02","pubTimestamp":1789232535,"startTime":"0","endTime":"0","summary":"截至2026年9月11日收盘，药明康德报收于151.24元，较上周的153.83元下跌1.68%。来自公司公告汇总：9月7日至9月11日，药明康德因可转换债券转换，多次发行H股，累计新增逾1700万股。公司公告汇总无锡药明康德新药开发股份有限公司于2026年9月7日因可转换债券转换，发行5,137,325股H股，每股发行价为港币153元。无锡药明康德新药开发股份有限公司于2026年9月8日因转换可转换债券发行H股6,321,703股，占发行前已发行股份的1.21%，每股发行价为港币153元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091300000020.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","LU1303224171.USD","BK1141","LU1997245094.SGD","LU1997244956.HKD","LU2328871848.SGD","LU1997245177.USD","LU0700851271.USD","LU1046422090.SGD","LU1934453819.USD","603259","LU1969619763.USD","LU0708995583.HKD","02359","LU2488822045.USD","LU1979443071.USD","LU1251922891.USD","BK1583","LU0456842615.SGD","LU0469268626.HKD","LU0327786744.USD","LU2495084118.USD","IE00BPRC5H50.USD","LU0611395673.USD","LU0572944931.SGD","LU0052750758.USD","IE00B5MMRT66.SGD","LU1770034418.SGD","LU0348766576.USD","LU1719994722.HKD","LU2045819591.USD","LU1808992512.USD","LU0348767384.USD","LU2125910500.SGD","BK1576","IE00B543WZ88.USD","LU0320764599.SGD","LU2242644610.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666835578","title":"药明康德（603259）披露H股因可转债转股新增发行公告，9月11日股价下跌2.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2666835578","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2666835578?lang=zh_cn&edition=full","pubTime":"2026-09-11 22:28","pubTimestamp":1789136906,"startTime":"0","endTime":"0","summary":"截至2026年9月11日收盘，药明康德报收于151.24元，较前一交易日下跌2.11%，最新总市值为4584.23亿元。该股当日开盘154.0元，最高154.36元，最低149.7元，成交额达45.89亿元，换手率为1.23%。近日，无锡药明康德新药开发股份有限公司提交翌日披露报表，因转换人民币6,780百万元于2027年到期的美元结算零息可转换债券，发行4,684,697股H股，每股发行价为港币153元。本次变动后，已发行H股总数由532,980,617股增至537,665,314股，已发行股份总数量由553,129,517股增至557,814,214股。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091100050289.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU0320764599.SGD","BK1576","LU0708995583.HKD","LU2488822045.USD","LU2495084118.USD","LU1969619763.USD","LU0700851271.USD","LU1251922891.USD","LU0572944931.SGD","LU1808992512.USD","LU1997245094.SGD","LU0469268626.HKD","BK0216","BK1583","LU1046422090.SGD","02359","IE00BPRC5H50.USD","LU0327786744.USD","LU2242644610.SGD","LU2045819591.USD","IE00B5MMRT66.SGD","LU0348767384.USD","LU0052750758.USD","LU0348766576.USD","LU0456842615.SGD","LU1303224171.USD","IE00B543WZ88.USD","603259","LU0611395673.USD","LU2328871848.SGD","LU1934453819.USD","LU1997244956.HKD","LU1997245177.USD","BK1141","LU2125910500.SGD","LU1719994722.HKD","LU1979443071.USD","LU1770034418.SGD"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1790854830943,"stockEarnings":[{"period":"1week","weight":-0.0036},{"period":"1month","weight":0.0847},{"period":"3month","weight":0.3841},{"period":"6month","weight":0.7058},{"period":"1year","weight":0.5225},{"period":"ytd","weight":0.8817}],"compareEarnings":[{"period":"1week","weight":-0.024},{"period":"1month","weight":-0.0362},{"period":"3month","weight":-0.0463},{"period":"6month","weight":-0.0098},{"period":"1year","weight":-0.0105},{"period":"ytd","weight":-0.0319}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"无锡药明康德新药开发股份有限公司","boardCode":"AI0073","boardName":"研究和试验发展","stockholders":"261368人(较上一季度减少8.34%)","perCapita":"9462股","listingDate":"2018-05-08","address":"江苏省无锡市滨湖区马山五号桥","registeredCapital":"303490万元","survey":" 无锡药明康德新药开发股份有限公司的主营业务是为全球医药及生命科学行业提供一体化、端到端的新药研发和生产服务。公司的主要产品是化学业务、测试业务、生物学业务、其他业务。","listedPrice":21.6},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"药明康德(603259)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供药明康德(603259)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"药明康德,603259,药明康德股票,药明康德股票老虎,药明康德股票老虎国际,药明康德行情,药明康德股票行情,药明康德股价,药明康德股市,药明康德股票价格,药明康德股票交易,药明康德股票购买,药明康德股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"药明康德(603259)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供药明康德(603259)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}